A Scoping Review Protocol to Explore the Use of Interleukin-1-Targeting Drugs for the Treatment of Dermatological Diseases: Indications, Mechanism of Action, Efficacy, and Safety

INTRODUCTION: The interleukin (IL)-1 pathway has been identified as being involved in inflammatory and neoplastic skin diseases such as psoriasis, atopic dermatitis, neutrophilic dermatosis, melanoma, and squamous cell carcinoma. Drugs developed to target the IL-1 pathway are currently used to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-García, Francisco, Ruano, Juan, Gay-Mimbrera, Jesús, Aguilar-Luque, Macarena, Sanz-Cabanillas, Juan L., Hernández Romero, José L., Garcia-Nieto, Antonio Velez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002324/
https://www.ncbi.nlm.nih.gov/pubmed/29626322
http://dx.doi.org/10.1007/s13555-018-0235-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002324/
https://www.ncbi.nlm.nih.gov/pubmed/29626322
http://dx.doi.org/10.1007/s13555-018-0235-4

Ejemplares similares